Sign in

CIK 0000906709

  • Non-accelerated filer
  • Smaller reporting company

NEKTAR THERAPEUTICS

Sign in to watch
Ticker
NKTR
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
EIN
943134940
Phone
+1 415-482-5300
Business address
455 MISSION BAY BOULEVARD SOUTH, SAN FRANCISCO, CA, 94158
Former names
INHALE THERAPEUTIC SYSTEMS INC, INHALE THERAPEUTIC SYSTEMS
  1. 4 Open-market sale President & CEO sold 83,334 shares at $23.57 ($1,964,182)
  2. 4 Open-market sale President & CEO sold 83,333 shares at $24.20 ($2,016,659)
  3. 4 Open-market sale SVP Pharma Dev & Mfg Ops sold 7,583 shares at $25.00 ($189,575)
  4. 4 Open-market sale SVP & Chief Scientific Officer sold 43,677 shares at $24.97 ($1,090,615)
  5. 4 Open-market sale SVP & Chief Financial Officer sold 120,000 shares at $24.45 ($2,934,000)
  6. 4 Open-market sale SVP & Chief Medical Officer sold 100,000 shares at an average $24.14 ($2,413,640)
  7. 4 Open-market sale Director sold 5,000 shares at $21.97 ($109,850)
  8. 4 Open-market sale Director sold 4,000 shares at $21.86 ($87,440)
  9. 4 Open-market sale Director sold 6,400 shares at $21.72 ($139,008)
  10. 4 Grant or award Director acquired 22,500 shares (grant or award)
  11. 4 Grant or award Director acquired 9,000 shares (grant or award)
  12. 4 Grant or award Director acquired 9,000 shares (grant or award)
  13. 4 Grant or award Director acquired 9,000 shares (grant or award)
  14. 4 Grant or award Director acquired 9,000 shares (grant or award)
  15. 4 Grant or award Director acquired 9,000 shares (grant or award)
  16. 4 Grant or award Director acquired 9,000 shares (grant or award)
  17. 4 Grant or award Director acquired 9,000 shares (grant or award)
  18. 3 Insider Initial Statement of Ownership
  19. 4 Open-market sale President & CEO sold 83,333 shares at $21.54 ($1,794,993)
  20. 4 Open-market sale SVP & Chief Accounting Officer sold 2,648 shares at $19.32 ($51,159)

Page 20 of 49 · 970 filings